52 related articles for article (PubMed ID: 28057716)
1. miR-211-5p Suppresses Metastatic Behavior by Targeting SNAI1 in Renal Cancer.
Wang K; Jin W; Jin P; Fei X; Wang X; Chen X
Mol Cancer Res; 2017 Apr; 15(4):448-456. PubMed ID: 28057716
[TBL] [Abstract][Full Text] [Related]
2. The miR-140-5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma.
Huang C; Li J; Zhang X; Xiong T; Ye J; Yu J; Gui Y
FASEB J; 2020 Aug; 34(8):10623-10639. PubMed ID: 32596959
[TBL] [Abstract][Full Text] [Related]
3. MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1.
Jin S; Chen L; Wu J; Chen M; Wang H; Hu H; Yu L; Zeng S
Int J Immunopathol Pharmacol; 2023; 37():3946320231184997. PubMed ID: 37584255
[TBL] [Abstract][Full Text] [Related]
4. circAMOTL1L Suppresses Renal Cell Carcinoma Growth by Modulating the miR-92a-2-5p/KLLN Pathway.
Gao L; Shao X; Yue Q; Wu W; Yang X; He X; Li L; Hou F; Zhang R
Oxid Med Cell Longev; 2021; 2021():9970272. PubMed ID: 34646428
[TBL] [Abstract][Full Text] [Related]
5. miR-145 Antagonizes SNAI1-Mediated Stemness and Radiation Resistance in Colorectal Cancer.
Zhu Y; Wang C; Becker SA; Hurst K; Nogueira LM; Findlay VJ; Camp ER
Mol Ther; 2018 Mar; 26(3):744-754. PubMed ID: 29475734
[TBL] [Abstract][Full Text] [Related]
6. SPARC is a key mediator of TGF-β-induced renal cancer metastasis.
Bao JM; Dang Q; Lin CJ; Lo UG; Feldkoren B; Dang A; Hernandez E; Li F; Panwar V; Lee CF; Cen JJ; Guan B; Margulis V; Kapur P; Brekken RA; Luo JH; Hsieh JT; Tan WL
J Cell Physiol; 2021 Mar; 236(3):1926-1938. PubMed ID: 32780451
[TBL] [Abstract][Full Text] [Related]
7. ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma.
Li T; Xu L; Wei Z; Zhang S; Liu X; Yang Y; Gu Y; Zhang J
Mol Cancer; 2023 Nov; 22(1):184. PubMed ID: 37980532
[TBL] [Abstract][Full Text] [Related]
8. HIF1A-repressed PUS10 regulates NUDC/Cofilin1 dependent renal cell carcinoma migration by promoting the maturation of miR-194-5p.
Luo W; Xu Z; Wang H; Lu Z; Ding L; Wang R; Xie H; Zheng Q; Lin Y; Zhou Z; Li Y; Chen X; Li G; Xia L
Cell Biosci; 2023 Aug; 13(1):153. PubMed ID: 37596681
[TBL] [Abstract][Full Text] [Related]
9. miR-211-5p is down-regulated and a prognostic marker in bladder cancer.
Wang W; Liu Z; Zhang X; Liu J; Gui J; Cui M; Li Y
J Gene Med; 2020 Dec; 22(12):e3270. PubMed ID: 32893379
[TBL] [Abstract][Full Text] [Related]
10. Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma.
Qin X; Zhang J; Lin Y; Sun XM; Zhang JN; Cheng ZQ
J Transl Med; 2020 Aug; 18(1):326. PubMed ID: 32859232
[TBL] [Abstract][Full Text] [Related]
11. miR-211-5p alleviates focal cerebral ischemia-reperfusion injury in rats by down-regulating the expression of COX2.
Peng Z; Li M; Tan X; Xiang P; Wang H; Luo Y; Yang Y; Huang H; Chen Z; Xia H; Li Y; Zhang J; Gu C; Liu M; Wang Q; Chen M; Yang J
Biochem Pharmacol; 2020 Jul; 177():113983. PubMed ID: 32311346
[TBL] [Abstract][Full Text] [Related]
12. Role of TRP channels in carcinogenesis and metastasis: Pathophysiology and regulation by non-coding RNAs.
Turgambayeva A; Duisekova S; Tashenova G; Tulebayeva A; Kapanova G; Akhenbekova A; Farooqi AA
Noncoding RNA Res; 2024 Jun; 9(2):359-366. PubMed ID: 38511066
[TBL] [Abstract][Full Text] [Related]
13. HOTAIR in colorectal cancer: structure, function, and therapeutic potential.
Tufail M
Med Oncol; 2023 Aug; 40(9):259. PubMed ID: 37530984
[TBL] [Abstract][Full Text] [Related]
14. miR-211-5p targeting MMP9 regulates the expressions of AQP4 in traumatic brain injury.
Wang M; Yu X; Li B; Gao C; Chen Y; Zhang X; Li W; Yang L; Fan Z
Acta Neurol Belg; 2023 Aug; 123(4):1321-1329. PubMed ID: 37020131
[TBL] [Abstract][Full Text] [Related]
15. Role and mechanism of miR-211 in human cancer.
Ye L; Wang F; Wang J; Wu H; Yang H; Yang Z; Huang H
J Cancer; 2022; 13(9):2933-2944. PubMed ID: 35912006
[TBL] [Abstract][Full Text] [Related]
16. MiR-211-5p Inhibits the Biological Behaviors of Colorectal Cancer via SPARC-Related Growth Factor Pathways.
Wu X; Chen Y; Zhu Y; Cui F
J Cancer; 2022; 13(6):1895-1904. PubMed ID: 35399721
[TBL] [Abstract][Full Text] [Related]
17. The Integrative Analysis of Competitive Endogenous RNA Regulatory Networks in Coronary Artery Disease.
Ji Y; Yan T; Zhu S; Wu R; Zhu M; Zhang Y; Guo C; Yao K
Front Cardiovasc Med; 2021; 8():647953. PubMed ID: 34631806
[No Abstract] [Full Text] [Related]
18. LncRNA DGCR5 Isoform-1 Silencing Suppresses the Malignant Phenotype of Clear Cell Renal Cell Carcinoma via miR-211-5p/Snail Signal Axis.
Zhong GX; Luo D; Fan YJ; Wang J; Liu BQ; Xu ZH; Zhang X
Front Cell Dev Biol; 2021; 9():700029. PubMed ID: 34322486
[TBL] [Abstract][Full Text] [Related]
19. Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical
Weidle UH; Nopora A
Cancer Genomics Proteomics; 2021; 18(3 Suppl):349-368. PubMed ID: 33994361
[TBL] [Abstract][Full Text] [Related]
20. A Review of Recent Research on the Role of MicroRNAs in Renal Cancer.
Yang L; Zou X; Zou J; Zhang G
Med Sci Monit; 2021 May; 27():e930639. PubMed ID: 33963171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
